A61K8/0208

Antiseptic wipes

A wipe includes a cleansing composition disposed on a cloth. The cleansing composition can include an antiseptic, a humectant, an emollient, a surfactant, and a monohydric alcohol. A wipe can be made by preparing a cleansing composition and disposing the cleansing composition on a cloth. Two or more wipes may be included in a sealed package to maintain the sterile state of the wipes. A method of disinfecting skin can include applying a wipe to skin.

Durable and dispersible creped multi-ply tissue

Disclosed are multi-ply tissue products comprising a non-crosslinked binder that are durable and dispersible. The products generally have a Slosh time less than 2 minutes, such as less than about 60 seconds, such as less than about 45 seconds. Surprisingly, the foregoing Slosh times are achieved despite the tissue products having relatively high cross-machine direction (CD) wet tensile strength, such as greater than about 100 g/3″. Typically, increasing wet tensile strength, particularly wet CD tensile strength, negatively effects dispersability and increases Slosh time. Despite this trend, the present invention surprisingly provides a tissue product having a relatively high degree of wet strength and good dispersability.

PORTION UNIT WITH COSMETIC PRODUCT FOR OXIDATIVE COLOR CHANGE OF KERATINOUS FIBERS
20220192937 · 2022-06-23 · ·

The present disclosure relates to a portion unit with at least one cosmetic product for oxidative color change of keratinous fibers, in particular human hair, filled receiving chamber, which is formed by a water-soluble envelope made of a water-soluble nonwoven fabric. Another object of the present disclosure is a method for oxidative dyeing of keratinous fibers, in particular human hair, using the portion unit.

PORTION UNIT WITH COSMETIC AGENT FOR LIGHTENING KERATINOUS FIBERS, ESPECIALLY HUMAN HAIR
20220192942 · 2022-06-23 · ·

The present disclosure relates to a portion unit having at least one receiving chamber filled with a cosmetic agent for lightening keratinous fibers, in particular human hair, which receiving chamber is formed by a water-soluble envelope made of a water-soluble nonwoven fabric.

MODIFIED ATMOSPHERE PACKAGING FOR SEALED COMPARTMENTS
20220194679 · 2022-06-23 ·

A container includes a compartment defining an inner volume, a plurality of cloth based products positioned within the inner volume of the compartment. The plurality of wipes are at least partially saturated in an aqueous solution. A gaseous mixture fills a remainder of the inner volume. The gaseous mixture includes less than 20% oxygen.

DYEING PROCESS USING PEROXYGENATED SALTS AND A SUBSTRATE COMPRISING OXIDATION DYES
20220183940 · 2022-06-16 · ·

The present invention relates to a process for dyeing keratin fibres, in particular human keratin fibres such as the hair, comprising the successive application to said fibres (i) of a composition (A) containing at least one peroxygenated salt and (ii) of a substrate including a surface totally or partially coated with at least one layer containing one or more oxidation dyes; said process does not use any hydrogen peroxide during the application of the substrate to the fibres.

3D BIOPRINTER USING PLANT STEM CELLS APPLIED TO SKIN TISSUE RECREATION FOR FACIAL REJUVENATION AND FACIAL BIOMASK FROM 3D BIOPRINTING
20220183935 · 2022-06-16 ·

A 3D (three dimensional) Bioprinter that uses plant stem cells applied to the recreation of skin tissue for facial rejuvenation, in addition to the facial biomask produced from the 3D bioprinter. The field of application of this utility model patent application is related to the Esthetics and Cosmetology industries. 3D bioprinting with plant stem cells is the latest and most revolutionary treatment for the prevention of aging and facial rejuvenation. It is a one hundred percent natural protocol for recreating the beauty of human skin.

Lactobacillus Gasseri KBL697 Strain and Use Thereof

A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.

DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS

Drug delivery systems and wearable articles including the drug delivery systems are provided. The drug delivery systems may include a substrate coated with at least one polymer and at least one active compound. The substrate is operable to include yarns, yarn precursors, threads, filaments, fibers, and/or other suitable substrates. Methods for manufacturing drug delivery systems are also provided. The methods are operable to include disposing a solution including a monomer and an active compound on the substrate. The methods are also operable to include exposing the solution and the substrate to UV light to initiate polymerization of the solution.

COMBINATION TREATMENT SYSTEMS

Controllers for dry eye treatment apparatus and methods are described herein which generally comprise a patch or strip affixed to the skin of the upper and/or lower eyelids to deliver heat to the one or more meibomian glands contained within the underlying skin. The treatment strip or strips include one or more strips configured to adhere to an underlying region of skin in proximity to one or both eyes of a subject such that the one or more strips allow for the subject to blink naturally without restriction from the one or more patches. A controller is in communication with the one or more strips and is programmable to monitor a temperature of the one or more strips to provide a treatment therapy above a threshold temperature. Additionally forceps for mechanically expressing the Meibomian glands may be included with the strips and/or controller.